Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein adiponectin appears protective against heart disease

21.01.2005


University of Pittsburgh findings published in leading European journal



Reduced blood concentrations of a protein called adiponectin appear to indicate a significant risk of cardiovascular disease in one of the first studies to focus on risk of the disorder among patients with diabetes mellitus type 1, previously known as juvenile diabetes. Recent studies suggest that adiponectin, a protein specific to fat tissue, is involved in obesity, diabetes and heart disease. Results of the study are published in the January issue of Diabetologia, a leading journal affiliated with the European Association for the Study of Diabetes.

"Most studies looking at adiponectin concentrations have been in the non-diabetic population or in people with type 2 diabetes," said Trevor Orchard, M.D., professor of epidemiology, medicine and pediatrics at the University of Pittsburgh Graduate School of Public Health (GSPH) and senior author of the study. "Given our previous work linking insulin resistance to heart disease in type 1 diabetes, we wanted to evaluate whether adiponectin levels in these individuals might be predictive of future cardiac events." Adiponectin has been closely linked with insulin resistance, a known risk factor for heart disease.


Adiponectin is one of the most abundant circulating proteins in human plasma, explained Dr. Orchard, who also is medical director of the nutrition lipid program at the University of Pittsburgh Medical Center, a clinic to which doctors refer patients with lipid metabolism disorders. "Adiponectin also seems to act as an anti-inflammatory molecule," he said.

Investigators found that for people with type 1 diabetes, decreased concentration of adiponectin was associated with increased risk for coronary artery disease (CAD). "Interestingly, this effect was independent of conventional risk factors such as smoking, cholesterol levels or body weight," said research associate Tina Costacou, Ph.D., the study’s first author. "Remarkably, it also was a better predicter than our markers for inflammation and insulin resistance, as well as other factors."

For the newest evaluation, participants were identified from the Pittsburgh Epidemiology of Diabetes Complications Study, a 10-year prospective follow-up study of childhood onset type 1 diabetes mellitus. In the study, patients with CAD were matched with controls who did not have heart disease. Blood samples from 28 cases and 34 controls were matched for gender, age and duration of diabetes.

"Regardless of CAD status, higher levels of adiponectin were observed among female participants in comparison to their male counterparts," said Dr. Costacou, explaining that adiponectin levels in blood samples from women averaged 20.8 micrograms per milliliter, versus 16.5 micrograms per milliliter for men. "This is a significant difference," she said.

Even independent of gender, however, results of the Pittsburgh study suggest that adiponectin has a substantial protective role against CAD. "There was a remarkable 63 percent reduction in risk of CAD for each 6.3 microgram per milliliter increase in serum adiponectin levels," said Dr. Orchard. "These results are striking despite the relatively small number of patients in the study. Our results – the first to show such a strong predictive power for heart disease prospectively in any population – raise the possibility that adiponectin concentration may prove not only a useful marker of cardiovascular risk, but also a potential therapeutic agent for prevention, particularly among high-risk individuals."

Michele D. Baum | EurekAlert!
Further information:
http://www.upmc.edu

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

Metallic nanoparticles will help to determine the percentage of volatile compounds

20.10.2017 | Materials Sciences

Shallow soils promote savannas in South America

20.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>